India to United States: Erlotinib Export Trade Route
India has recorded 25 verified shipments of Erlotinib exported to United States, representing a combined trade value of $281.6K USD. This corridor is served by 6 active Indian exporters, with an average shipment value of $11.3K USD. The leading Indian exporter is MSN LABORATORIES PRIVATE LIMITED, which accounts for 45% of total export value with 8 shipments worth $126.1K USD. On the buying side, J. KNIPPER & COMPANY is the largest importer in United States with $106.9K USD in purchases. The top 3 suppliers — MSN LABORATORIES PRIVATE LIMITED, ALEMBIC PHARMACEUTICALS LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED — together control 90% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United States Erlotinib corridor is one of India's established pharmaceutical export routes, with 25 shipments documented worth a combined $281.6K USD. The route is dominated by MSN LABORATORIES PRIVATE LIMITED, which alone accounts for roughly 45% of all export value, reflecting the consolidated nature of India's erlotinib manufacturing sector.
Across 6 active suppliers, the average shipment value stands at $11.3K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 79% of all shipments, consistent with erlotinib's non-urgent bulk-order profile.
Shipment activity peaks during January–March, with an average transit time of 24 days port-to-port. The route has recorded an annual growth rate of 13.1%, placing it at rank #19 among India's top erlotinib export destinations globally.
On the import side, key buyers of Indian erlotinib in United States include J. KNIPPER & COMPANY, TO THE ORDER OF, NOVADOZ PHARMACEUTICALS LLC and 6 others. J. KNIPPER & COMPANY is the single largest importer with 6 shipments valued at $106.9K USD.
Route Characteristics
- Average transit24 days
- Peak seasonQ1
- Primary modeSea freight
- Top portSAHAR AIR CARGO ACC (INBOM4)
Market Position
- Global rank#19
- Annual growth+13.1%
- Demand growth+13.4%
- Regulatory ease82/100
Top 10 Indian Erlotinib Exporters to United States
Showing top 10 of 6 Indian suppliers exporting Erlotinib to United States, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | MSN LABORATORIES PRIVATE LIMITED Avg $15.8K per shipment | 8 | $126.1K | 44.8% |
| 2 | ALEMBIC PHARMACEUTICALS LIMITED Avg $17.8K per shipment | 6 | $106.9K | 38.0% |
| 3 | SUN PHARMACEUTICAL INDUSTRIES LIMITED Avg $2.5K per shipment | 8 | $20.1K | 7.1% |
| 4 | ZYDUS LIFESCIENCES LIMITED Avg $14.1K per shipment | 1 | $14.1K | 5.0% |
| 5 | CADILA HEALTHCARE LIMITED Avg $14.0K per shipment | 1 | $14.0K | 5.0% |
| 6 | ATLAS ENTERPRISES Avg $453 per shipment | 1 | $453 | 0.2% |
This table shows the top 10 of 6 Indian companies exporting erlotinib to United States, ranked by total trade value. The listed exporters are: MSN LABORATORIES PRIVATE LIMITED, ALEMBIC PHARMACEUTICALS LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED, ZYDUS LIFESCIENCES LIMITED, CADILA HEALTHCARE LIMITED, ATLAS ENTERPRISES. MSN LABORATORIES PRIVATE LIMITED is the dominant supplier with 8 shipments worth $126.1K USD, giving it a 45% market share. The top 3 suppliers together account for 90% of the total trade value on this route.
Top 10 Erlotinib Importers in United States
Showing top 10 of 9 known buyers in United States receiving Erlotinib shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian erlotinib in United States include J. KNIPPER & COMPANY, TO THE ORDER OF, NOVADOZ PHARMACEUTICALS LLC, SUN PHARMACEUTICAL INDUSTRIES,INC., TO THE ORDER, among 9 total buyers. The largest importer is J. KNIPPER & COMPANY, accounting for $106.9K USD across 6 shipments — representing 38% of all erlotinib imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | J. KNIPPER & COMPANY | 6 | $106.9K | 38.0% |
| 2 | TO THE ORDER OF | 5 | $73.0K | 25.9% |
| 3 | NOVADOZ PHARMACEUTICALS LLC | 2 | $35.7K | 12.7% |
| 4 | SUN PHARMACEUTICAL INDUSTRIES,INC. | 4 | $20.1K | 7.1% |
| 5 | TO THE ORDER | 1 | $17.4K | 6.2% |
| 6 | XXDUSXXHARXXCEUXXCALXXUSAXXNC | 1 | $14.1K | 5.0% |
| 7 | ZYDUS PHARMACEUTICALS USA INC | 1 | $14.0K | 5.0% |
| 8 | VERONICA HERNANDEZ | 1 | $453 | 0.2% |
| 9 | SUN PHARMACEUTICAL INDUSTRIES INC | 4 | $15 | 0.0% |
Top 10 Erlotinib Formulations Imported by United States
Showing top 10 of 21 product formulations shipped on the India to United States Erlotinib route, ranked by trade value
United States imports a wide range of erlotinib formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — ERLOTINIB TABLETS 25MG, 30S, AP US DETAILS AS PER INVOICE — accounts for $63.8K USD across 1 shipments. There are 21 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | ERLOTINIB TABLETS 25MG, 30S, AP US DETAILS AS PER INVOICE | 1 | $63.8K | 22.7% |
| 2 | ERLOTINIB TAB 150MG 30'S NOVADOZ | 2 | $44.0K | 15.6% |
| 3 | ERLOTINIB TAB 25 MG - 1 X 30. | 2 | $28.1K | 10.0% |
| 4 | ERLOTINIB TABLET 100 MG | 1 | $23.9K | 8.5% |
| 5 | ERLOTINIB TAB 150MG 30 S NOVADOZ | 1 | $19.6K | 7.0% |
| 6 | MSN PHARMA-ERLOTINIB TABLET 100MG 30S NOVADOZ NDC NO:72205-081-30 | 1 | $17.4K | 6.2% |
| 7 | ERLOTINIB TABLETS 100MG, 30S, AP US DETAILS AS PER INVOICE | 1 | $17.2K | 6.1% |
| 8 | ERLOTINIB TAB 150MG 30's NOVADOZ (492 X30'S PACK = 14760 NOS) | 1 | $11.8K | 4.2% |
| 9 | ERLOTINIB TABLETS 150MG PACK : 30 TABLET | 1 | $11.0K | 3.9% |
| 10 | ERLOTINIB TABLETS 150MG, 30'S, AP US | 1 | $8.6K | 3.0% |
Showing top 10 of 21 Erlotinib formulations imported by United States on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 79%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
SAHAR AIR CARGO ACC (INBOM4) handles the highest volume with 5 shipments. Transit time averages 24 days by sea.
Market Dynamics
India's erlotinib exports to United States are driven primarily by a handful of large-scale manufacturers. MSN LABORATORIES PRIVATE LIMITED with 8 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 6 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — MSN LABORATORIES PRIVATE LIMITED, ALEMBIC PHARMACEUTICALS LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED — together account for 90% of total trade value on this route. The average shipment value of $11.3K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as erlotinib tab 150mg 30's novadoz and erlotinib tab 25 mg - 1 x 30., suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, J. KNIPPER & COMPANY is the largest importer with 6 shipments worth $106.9K USD — representing 38% of all erlotinib imports from India on this route. A total of 9 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $281.6K
- Avg. Shipment
- $11.3K
- Suppliers
- 6
- Buyers
- 9
- Transit (Sea)
- ~24 days
- Annual Growth
- +13.1%
Other Erlotinib Routes
Unlock the Full India to United States Erlotinib Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 25 shipments on this route.
Frequently Asked Questions — India to United States Erlotinib Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Erlotinib to United States?
The leading Indian exporters of Erlotinib to United States are MSN LABORATORIES PRIVATE LIMITED, ALEMBIC PHARMACEUTICALS LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED. MSN LABORATORIES PRIVATE LIMITED holds the largest market share at approximately 45% of total trade value on this route.
Q What is the total value of Erlotinib exports from India to United States?
India exports Erlotinib to United States worth approximately $281.6K USD across 25 recorded shipments. The average value per shipment is $11.3K USD.
Q Which ports does India use to ship Erlotinib to United States?
The most active port of origin is SAHAR AIR CARGO ACC (INBOM4) with 5 shipments. Indian exporters primarily use sea freight for this route, with 79% of shipments going by sea and 25% by air.
Q How long does shipping take from India to United States for Erlotinib?
The average transit time for Erlotinib shipments from India to United States is approximately 24 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during January–March.
Q Is the India to United States Erlotinib trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 13.1% with demand growth tracking at 13.4%. The route is ranked #19 among India's top Erlotinib export destinations globally.
Q How many suppliers are active on the India to United States Erlotinib route?
There are currently 6 active Indian suppliers exporting Erlotinib to United States. The market is moderately concentrated with MSN LABORATORIES PRIVATE LIMITED accounting for 45% of total shipment value.
Q Who are the main importers of Erlotinib from India in United States?
The leading importers of Indian Erlotinib in United States include J. KNIPPER & COMPANY, TO THE ORDER OF, NOVADOZ PHARMACEUTICALS LLC, SUN PHARMACEUTICAL INDUSTRIES,INC., TO THE ORDER. J. KNIPPER & COMPANY is the largest buyer with 6 shipments worth $106.9K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to United States export trade corridor identified from Indian Customs (DGFT) records for Erlotinib.
- 2.Supplier/Buyer Matching: 6 Indian exporters and 9 importers in United States matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 25 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
25 Verified Shipments
6 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists